About Wellthy Therapeutics
Wellthy Therapeutics is a company based in Mumbai (India) founded in 2015 by Prayat Shah and Sneha Shah was acquired by TruDoc in February 2024.. Wellthy Therapeutics has raised $8.91 million across 6 funding rounds from investors including India Infoline, IIFL Finance and Bayer. The company has 38 employees as of March 31, 2024. Wellthy Therapeutics offers products and services including Digital Care Operating System and Type 2 Diabetes Management App. Wellthy Therapeutics operates in a competitive market with competitors including DarioHealth, Welldoc, Pear Therapeutics, Spiras Health and Ciba Health, among others.
- Headquarter Mumbai, India
- Employees 38 as on 31 Mar, 2024
- Founders Prayat Shah, Sneha Shah
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Wellthy Therapeutics Private Limited
- Date of Incorporation 02 Dec, 2015
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$501.33 K (USD)26.85as on Mar 31, 2022
-
Net Profit
$-1.6 M (USD)10.96as on Mar 31, 2022
-
EBITDA
$-1.62 M (USD)6.32as on Mar 31, 2022
-
Total Equity Funding
$8.91 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
India Infoline
& 25 more
-
Employee Count
38
as on Mar 31, 2024
-
Acquired by
TruDoc
(Feb 12, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Wellthy Therapeutics
Wellthy Therapeutics offers a comprehensive portfolio of products and services, including Digital Care Operating System and Type 2 Diabetes Management App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables digital solutions for chronic disease management and outcomes tracking
Assists in diet, exercise, and blood sugar control for patients
Unlock access to complete
Funding Insights of Wellthy Therapeutics
Wellthy Therapeutics has successfully raised a total of $8.91M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(21 Dec 2017)
- Investors Count 25
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Seed - Wellthy Therapeutics | Valuation | Beyond Next Ventures |
|
| Apr, 2021 | Amount | Seed - Wellthy Therapeutics | Valuation | Bayer |
|
| Apr, 2020 | Amount | Seed - Wellthy Therapeutics | Valuation | Saama Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Wellthy Therapeutics
Wellthy Therapeutics has secured backing from 26 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include India Infoline, IIFL Finance and Bayer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
|
Founded Year | Domain | Location | |
|
Venture capital investments and partnerships in diverse sectors.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital fund
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Wellthy Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Wellthy Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wellthy Therapeutics Comparisons
Competitors of Wellthy Therapeutics
Wellthy Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DarioHealth, Welldoc, Pear Therapeutics, Spiras Health and Ciba Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chronic conditions are managed via a personalized digital platform.
|
|
| domain | founded_year | HQ Location |
Mobile health products for chronic disease management are offered.
|
|
| domain | founded_year | HQ Location |
Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively.
|
|
| domain | founded_year | HQ Location |
Asthma and COPD symptoms are managed through clinical services.
|
|
| domain | founded_year | HQ Location |
Provider of teleconsultation and digital therapeutic software for employees and patients
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Wellthy Therapeutics
Frequently Asked Questions about Wellthy Therapeutics
When was Wellthy Therapeutics founded?
Wellthy Therapeutics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Wellthy Therapeutics located?
Wellthy Therapeutics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Is Wellthy Therapeutics a funded company?
Wellthy Therapeutics is a funded company, having raised a total of $8.91M across 6 funding rounds to date. The company's 1st funding round was a Seed of $4.11M, raised on Dec 21, 2017.
How many employees does Wellthy Therapeutics have?
As of Mar 31, 2024, the latest employee count at Wellthy Therapeutics is 38.
What is the annual revenue of Wellthy Therapeutics?
Annual revenue of Wellthy Therapeutics is $501.33K as on Mar 31, 2022.
What does Wellthy Therapeutics do?
Wellthy Therapeutics was founded in 2015 in Mumbai, India, within the health technology sector. A platform is offered that integrates with smart devices to track vital signs of patients with chronic conditions, including diabetes, hypertension, heart failure, and chronic kidney disease. Health data is visualized remotely by providers and caregivers. Lifestyle management programs are provided for chronic disease support, alongside a dashboard for monitoring patient progress.
Who are the top competitors of Wellthy Therapeutics?
Wellthy Therapeutics's top competitors include Welldoc, DarioHealth and Ciba Health.
What products or services does Wellthy Therapeutics offer?
Wellthy Therapeutics offers Digital Care Operating System and Type 2 Diabetes Management App.
Who are Wellthy Therapeutics's investors?
Wellthy Therapeutics has 26 investors. Key investors include India Infoline, IIFL Finance, Bayer, Manipal Group, and Cipla.
What is Wellthy Therapeutics's valuation?
The valuation of Wellthy Therapeutics is $25.37M as of Apr 2021.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.